Scinai Immunotherapeutics (SCNI) Stock: Buy, Sell, or Hold?
SCNI - Scinai Immunotherapeutics Ltd. American Depositary Shares
$0.60
-0.01 (-1.13%)
▼
5d:
-33.08%
30d:
-69.53%
90d:
+162.3%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 23, 2026
Get Alerted When SCNI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SCNI is down 33.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SCNI is down 33.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SCNI is currently trading at $0.60, which is considered oversold relative to its 30-day fair value range of $0.99 to $1.77.
Technical Outlook: Technically, SCNI is in a uptrend. Immediate support is located at $0.55, while resistance sits at $1.76.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $700.00 (+114616.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCNI is in a uptrend. Immediate support is located at $0.55, while resistance sits at $1.76.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $700.00 (+114616.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.99 -
$1.77
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 114616.5% below Wall St target ($700.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.99 -
$1.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.55
Resistance Level
$1.76
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Wall Street Target
$700.00
(+114616.5%)
Revenue Growth (YoY)
146.0%
Earnings Growth (YoY)
87.2%
Profit Margin
-174.8%
Share & Embed Analysis
Last updated: October 22, 2026 3:01 PM ET
Data refreshes hourly during market hours. Next update: 4:01 PM
Data refreshes hourly during market hours. Next update: 4:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCNI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |